Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,27 USD | -3,40% | -5,42% | -24,58% |
Attività
Numero di dipendenti: 94
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Programmable Epigenomic mRNA Medicines
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +49,25% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +49,25% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mahesh Karande
CEO | Chief Executive Officer | 51 | 01/06/19 |
Joshua Reed
DFI | Director of Finance/CFO | 51 | 23/05/22 |
Chief Tech/Sci/R&D Officer | - | 01/01/21 | |
Samir Padalkar
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/21 |
Ling Zeng
ADM | Chief Administrative Officer | 55 | 30/03/22 |
Thomas McCauley
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/07/19 |
Yan Moore
CTO | Chief Tech/Sci/R&D Officer | 58 | 10/01/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Luke Beshar
BRD | Director/Board Member | 65 | 01/05/21 |
John Mendlein
BRD | Director/Board Member | 64 | 01/01/20 |
Christian Schade
CHM | Chairman | 63 | 10/07/23 |
Mary Szela
BRD | Director/Board Member | 61 | 01/06/19 |
Richard Young
BRD | Director/Board Member | 70 | 01/08/17 |
Michelle Werner
BRD | Director/Board Member | - | 28/08/23 |
Elliott Levy
BRD | Director/Board Member | 64 | 01/03/21 |
Rainer Boehm
BRD | Director/Board Member | 63 | 01/09/22 |
Mahesh Karande
CEO | Chief Executive Officer | 51 | 01/06/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 55 154 985 | 50 558 255 ( 91,67 %) | 0 | 91,67 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-24,58% | 125 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione OMGA
- Società Omega Therapeutics, Inc.